Northwestern first site open for spinal cord stem cell trial
Wednesday, September 22, 2010 - 10:42
in Health & Medicine
Northwestern Medicine is the first site open for enrollment in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. Following the procedure, participants will receive rehabilitation treatment at The Rehabilitation Institute of Chicago (RIC).